| Laura Ardell Love-williams, LPN | |
|
627 Shorter Ave, Attalla, AL 35954-2838 | |
| (256) 691-5201 | |
| Not Available |
| Full Name | Laura Ardell Love-williams |
|---|---|
| Gender | Female |
| Speciality | Licensed Practical Nurse |
| Location | 627 Shorter Ave, Attalla, Alabama |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1245096874 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 164W00000X | Licensed Practical Nurse | 2064698 (Alabama) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Laura Ardell Love-williams, LPN 627 Shorter Ave, Attalla, AL 35954-2838 Ph: (256) 691-5201 | Laura Ardell Love-williams, LPN 627 Shorter Ave, Attalla, AL 35954-2838 Ph: (256) 691-5201 |
News Archive
Hyaluronic acid (HA) fillers are a popular treatment for facial lines and wrinkles, but early degradation of fillers may limit how long their effects last. Experimental evidence supports a simple technique for prolonging the effects of HA dermal fillers: using them together with botulinum toxin, reports a paper in the January issue of Plastic and Reconstructive Surgery, the official medical journal of the American Society of Plastic Surgeons (ASPS).
A drug that removes excess iron and toxins from the body after a brain bleed did not show significant improvement in recovery or neurological function at three months after intracerebral hemorrhage (stroke), but showed some benefits at six months, according to late breaking science presented at the American Stroke Association's International Stroke Conference 2019, a world premier meeting for researchers and clinicians dedicated to the science and treatment of cerebrovascular disease.
Targacept, Inc., a clinical-stage biopharmaceutical company developing novel NNR Therapeutics (TM), today announced that it has been awarded a grant of $304,000 from The Michael J. Fox Foundation for Parkinson's Research (MJFF). The grant is to fund a project entitled: "Development of an alpha6*-selective Neuronal Nicotinic Receptor (NNR) Imaging Agent as a Parkinson's Disease Biomarker" and is the second awarded to Targacept by MJFF in the last six months.
Researchers at Johns Hopkins have shown that brain damage was reduced by as much as 62.2 percent in mice who inhale low amounts of carbon monoxide after an induced stroke.
Children exposed to at least one course of antibiotics in their first year of life may have an increased risk of developing childhood asthma.
› Verified 9 days ago